grant

Lipoceramic Technologies: a Solution to Low and Variable Bioavailability of Poorly Soluble Anti-inflammatory Drugs [ 2009 - 2009 ]

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/570134]

Researchers: Prof Clive Prestidge (Principal investigator) ,  Prof Andrew Davey Prof Ben Boyd

Brief description A novel oral drug delivery platform will be developed that improves the absorption of poorly soluble drugs from the GI tract, leads to improved clinical outcomes and has significant commercial value. This development will be based on the combination of formulation, in vitro analysis and in vivo animal model studies. An advanced prototype formulation will be established for celecoxib (a non-steroidal anti-inflamatory drug) that will be suitable for human phase 1 clinical trials.

Funding Amount $AUD 200,600.00

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]